At Velocity in Annapolis, MD, clinical research is delivered as part of everyday healthcare.
Located on the Anne Arundel Medical Center campus, the site is embedded within a broader care environment, allowing patients to access clinical trials in the same place they already receive treatment.
Turning Access Into Opportunity
The Annapolis site serves a population of more than 1.8 million people across surrounding counties, with direct connections to family medicine practices and a wide range of specialties including cardiology, oncology, and women’s health.
This creates a consistent and scalable recruitment model. Patients can be identified through their existing care pathways, screened efficiently, and enrolled without leaving their local health system.
The result is high-quality recruitment across a broad set of therapeutic areas, including oncology, metabolic disease, vaccines, and behavioral health.
Expanding Access to Clinical Trials
For patients, the impact is immediate. Participation in clinical research offers access to investigational treatments that may not yet be widely available, often without the need to travel to academic centers.
By embedding research within a familiar care setting, the site lowers barriers to entry and makes clinical trials more accessible to a broader and more diverse population.
Delivering Research at Scale
The Annapolis site combines experienced investigators with dedicated research infrastructure and access to hospital-based services such as imaging, infusion, and diagnostics.
With more than 60 active trials and over 10 investigators across multiple specialties, the site is equipped to deliver complex, high-volume studies with consistency and efficiency.
Velocity Annapolis reflects a shift in how clinical research is delivered. By integrating trials into real-world care environments, it expands access, improves performance, and brings research closer to the patients it is designed to serve.
